These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23997996)
1. Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression. Hahn-Holbrook J; Schetter CD; Arora C; Hobel CJ Clin Psychol Sci; 2013 Jul; 1(3):253-264. PubMed ID: 23997996 [TBL] [Abstract][Full Text] [Related]
2. Placental corticotrophin-releasing hormone trajectories in pregnancy: Associations with postpartum depressive symptoms. Almeida IF; Rinne GR; Coussons-Read M; Dunkel Schetter C Psychoneuroendocrinology; 2024 Jun; 164():107030. PubMed ID: 38537413 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms. Glynn LM; Sandman CA Psychosom Med; 2014 Jun; 76(5):355-62. PubMed ID: 24915294 [TBL] [Abstract][Full Text] [Related]
4. Increases in maternal depressive symptoms during pregnancy and infant cortisol reactivity: Mediation by placental corticotropin-releasing hormone. Rinne GR; Somers JA; Ramos IF; Ross KM; Coussons-Read M; Dunkel Schetter C Dev Psychopathol; 2023 Oct; 35(4):1997-2010. PubMed ID: 35983792 [TBL] [Abstract][Full Text] [Related]
5. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Glynn LM; Davis EP; Sandman CA Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135 [TBL] [Abstract][Full Text] [Related]
6. Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Yim IS; Glynn LM; Dunkel-Schetter C; Hobel CJ; Chicz-DeMet A; Sandman CA Arch Gen Psychiatry; 2009 Feb; 66(2):162-9. PubMed ID: 19188538 [TBL] [Abstract][Full Text] [Related]
7. Interaction between the functional SNP rs2070951 in NR3C2 gene and high levels of plasma corticotropin-releasing hormone associates to postpartum depression. Gutiérrez-Zotes A; Díaz-Peña R; Costas J; Martorell L; Gelabert E; Sans T; Navinés R; Albacar G; Ímaz ML; García-Esteve L; Sanjuan J; Martín-Santos R; Carracedo A; Vilella E Arch Womens Ment Health; 2020 Jun; 23(3):413-420. PubMed ID: 31388769 [TBL] [Abstract][Full Text] [Related]
8. Fetal exposure to placental corticotropin-releasing hormone is associated with child self-reported internalizing symptoms. Howland MA; Sandman CA; Glynn LM; Crippen C; Davis EP Psychoneuroendocrinology; 2016 May; 67():10-7. PubMed ID: 26855003 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy anxiety, placental corticotropin-releasing hormone and length of gestation. Ramos IF; Ross KM; Rinne GR; Somers JA; Mancuso RA; Hobel CJ; Coussons-Read M; Dunkel Schetter C Biol Psychol; 2022 Jul; 172():108376. PubMed ID: 35667479 [TBL] [Abstract][Full Text] [Related]
11. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Wadhwa PD; Porto M; Garite TJ; Chicz-DeMet A; Sandman CA Am J Obstet Gynecol; 1998 Oct; 179(4):1079-85. PubMed ID: 9790402 [TBL] [Abstract][Full Text] [Related]
12. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Hobel CJ; Dunkel-Schetter C; Roesch SC; Castro LC; Arora CP Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 3):S257-63. PubMed ID: 9914629 [TBL] [Abstract][Full Text] [Related]
13. Sex-specific associations between placental corticotropin releasing hormone and problem behaviors in childhood. Barrett ES; Sullivan A; Workman T; Zhang Y; Loftus CT; Szpiro AA; Paquette A; MacDonald JW; Coccia M; Smith R; Bowman M; Smith A; Derefinko K; Nguyen RHN; Zhao Q; Sathyanarayana S; Karr C; LeWinn KZ; Bush NR Psychoneuroendocrinology; 2024 May; 163():106994. PubMed ID: 38387218 [TBL] [Abstract][Full Text] [Related]
14. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Mastorakos G; Ilias I Ann N Y Acad Sci; 2003 Nov; 997():136-49. PubMed ID: 14644820 [TBL] [Abstract][Full Text] [Related]
15. Prenatal phthalate exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE cohort. Barrett ES; Corsetti M; Day D; Thurston SW; Loftus CT; Karr CJ; Kannan K; LeWinn KZ; Smith AK; Smith R; Tylavsky FA; Bush NR; Sathyanarayana S Environ Int; 2022 Feb; 160():107078. PubMed ID: 35007898 [TBL] [Abstract][Full Text] [Related]
16. Prenatal polycyclic aromatic hydrocarbon (PAH) exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE pregnancy cohort. Barrett ES; Workman T; Hazlehurst MF; Kauderer S; Loftus C; Kannan K; Robinson M; Smith AK; Smith R; Zhao Q; LeWinn KZ; Sathyanarayana S; Bush NR Front Endocrinol (Lausanne); 2022; 13():1011689. PubMed ID: 36440232 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing hormone and cortisol: longitudinal associations with depression and antisocial behavior in pregnant adolescents. Susman EJ; Schmeelk KH; Worrall BK; Granger DA; Ponirakis A; Chrousos GP J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):460-7. PubMed ID: 10199119 [TBL] [Abstract][Full Text] [Related]
19. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Marinoni E; Korebrits C; Di Iorio R; Cosmi EV; Challis JR Am J Obstet Gynecol; 1998 Apr; 178(4):770-8. PubMed ID: 9579442 [TBL] [Abstract][Full Text] [Related]